Obzone Pharmaceuticals Pvt. Ltd. Company Profile

07:59 EDT 23rd October 2016 | BioPortfolio

Obzone Pharmaceuticals Pvt. Ltd. is proud to introduce itself as the marketing wing of the Ciron Group - a fully integrated specialty pharmaceutical formulations group engaged in researching, developing, manufacturing and marketing a spectrum of pharmaceutical formulations in India.
Since its inception Obzone has been wholly focused on the twin objectives of availability and affordability. We seek to serve the broadest possible spectrum of patients of all economic strata by bringing them a formulations portfolio across a wide range of therapeutic areas and at the most reasonable costs.
Every product is backed by the Ciron Group’s reputation for consistent quality and constant innovation. Headquartered in Mumbai, the Group comprises of Ciron Drugs & Pharmaceuticals Pvt. Ltd., Healthy Life Pharma Pvt. Ltd. and Oboi Laboratories. State-of-the-art WHO GMP certified manufacturing units are located in Tarapur. The Ciron Group is dedicated to delivering the highest possible levels of customer satisfaction, through top quality, an expanding a range of pharmaceutical formulations and timely deliveries


1, Saryu Co. Hsg. Society,Vaishali Nagar, Jogeshwari (W)


Phone: 91-22-2678 9322
Fax: 91-22-2678 0784

News Articles [1496 Associated News Articles listed on BioPortfolio]

Jazz Pharmaceuticals Acquires Celator for $1.5B

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today announced that they have entered into a definitive agreement for Jazz Pharmaceuticals to acquire Celator ...

M&As this week: Scintilla Pharmaceuticals, Lonza Group Ltd, Piramal Enterprises Limited

Scintilla Pharmaceuticals has entered a binding term sheet to acquire Semnur Pharmaceuticals for a purchase consideration of up to $200m.

Jazz Pharmaceuticals to Acquire Celator

NewsJazz Pharmaceuticals and Celator Pharmaceuticals announce agreement for Jazz Pharmaceuticals to acquire Celator for $30.25 per share.

Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To ...

1Included secondary AML and de novo AML with a karyotype characteristic of myelodysplastic syndrome (MDS) 2 U.S. FDA Breakthrough Therapy designat...

Delisting and regulator's inaction failed to improve market capitalization of pharma entities

The Bombay Stock Exchange (BSE) authorities have suspended major companies from pharmaceutical segment like Elder Pharmaceuticals, Surya Pharmaceuticals, Plethico Pharmaceuticals, Twilight Litaka, Dr

Novartis splits pharmaceuticals division into two business units

Novartis has announced internal structural changes that it says will “focus” its pharmaceuticals division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology, reporting ...

Scintilla to Acquire SCILEX Pharmaceuticals

NewsScintilla Pharmaceuticals to acquire SCILEX Pharmaceuticals to add a late-stage asset to bolster its pain management business.

M&As this week: Savara Pharma, Xiangxue Pharmaceuticals

Savara Pharmaceuticals plans to expand its pipeline of orphan respiratory drugs by acquiring Serendex Pharmaceuticals, a provider of inhalation therapies for rare respiratory conditions.

Drugs and Medications [0 Results]


PubMed Articles [148 Associated PubMed Articles listed on BioPortfolio]

Biotransformation of pharmaceuticals by ammonia oxidizing bacteria in wastewater treatment processes.

Pharmaceutical residues could potentially pose detrimental effects on aquatic ecosystems and human health, with wastewater treatment being one of the major pathways for pharmaceuticals to enter into t...

Announcing the 2016 Pharmaceuticals Travel Award for Young Investigators.

For the first time in its short history, our journal is able, this year, to support a young researcher in the field of medicinal chemistry by offering a travel grant of 800 CHF.[...].

Uptake, depuration, and bioconcentration of two pharmaceuticals, roxithromycin and propranolol, in Daphnia magna.

The objective of the present study was to investigate the uptake, depuration, and bioconcentration of two pharmaceuticals, roxithromycin (ROX) and propranolol (PRP), in Daphnia magna via aqueous expos...

Photosynthetic sensitivity of phytoplankton to commonly used pharmaceuticals and its dependence on cellular phosphorus status.

Recently pharmaceuticals have become significant environmental pollutants in aquatic ecosystems, that could affect primary producers such as microalgae. Here we analyzed the effect of pharmaceuticals ...

Occurrence of pharmaceuticals and cocaine in a Brazilian coastal zone.

The present study determined environmental concentrations of pharmaceuticals, cocaine, and the main human metabolite of cocaine in seawater sampled from a subtropical coastal zone (Santos, Brazil). Th...

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

This is a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceut...

Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product

An Open-Label, Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use DSXS topical product (Taro Pharmaceuticals U.S.A., Inc.) in Patients with Moderate to Seve...

T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation.

This study evaluates the frequency of occurrence, severity, and response to treatment by a chemical agent, notably the dimerizer AP1903 (Bellicum Pharmaceuticals compagny), in the case of ...

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression Following Treatment with DSXS (Taro Pharmaceuticals U.S.A., Inc.) in Patients with Plaque Psoriasis

TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV

The primary objective of this study is to continue to provide Darunavir (DRV) to pediatric patients who previously received DRV in any of three pediatric clinical studies sponsored by Tibo...

Companies [1 Associated Companies listed on BioPortfolio]

Obzone Pharmaceuticals Pvt. Ltd.

Obzone Pharmaceuticals Pvt. Ltd. is proud to introduce itself as the marketing wing of the Ciron Group - a fully integrated specialty pharmaceutical formulations group engaged in researching, developi...

More Information about "Obzone Pharmaceuticals Pvt. Ltd." on BioPortfolio

We have published hundreds of Obzone Pharmaceuticals Pvt. Ltd. news stories on BioPortfolio along with dozens of Obzone Pharmaceuticals Pvt. Ltd. Clinical Trials and PubMed Articles about Obzone Pharmaceuticals Pvt. Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Obzone Pharmaceuticals Pvt. Ltd. Companies in our database. You can also find out about relevant Obzone Pharmaceuticals Pvt. Ltd. Drugs and Medications on this site too.

Quick Search

Relevant Topic

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Corporate Database Quicklinks

Searches Linking to this Company Record